Skip to Content
Diagnosed with PsA? Learn about biologics >

Alefacept Pregnancy and Breastfeeding Warnings

Alefacept is also known as: Amevive

Alefacept Pregnancy Warnings

Women of childbearing potential make up a considerable segment of the patient population affected by psoriasis. Because the effect of alefacept on pregnancy and fetal development is not known, health care providers are encouraged by Biogen to enroll patients currently taking alefacept who become pregnant into the Biogen Pregnancy Registry by calling 1-866-AMEVIVE (1-866-263-8483).

Alefacept has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal any evidence of fetal toxicity including adverse effects on immune system development. There are no controlled data in human pregnancy. Alefacept should be given during pregnancy when need has been clearly established.

See references

Alefacept Breastfeeding Warnings

There are no data on the excretion of alefacept into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to alefacept in nursing infants, a decision should be made to discontinue nursing or discontinue the use of the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Amevive (alefacept)." Biogen, Cambridge, MA.

References for breastfeeding information

  1. "Product Information. Amevive (alefacept)." Biogen, Cambridge, MA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.